| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |